Director John C. Kennedy receives 5,626-share GENTEX (GNTX) stock grant

Rhea-AI Filing Summary

KENNEDY JOHN C reported acquisition or exercise transactions in this Form 4 filing.

GENTEX CORP director John C. Kennedy reported an equity award of 5,626 shares of Common Stock. The shares were granted at no cash cost to him as a compensation award and will vest 100% one year from the grant date. Following this grant, he holds 5,626 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KENNEDY JOHN C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,626	$0.00	--

Holdings After Transaction: Common Stock — 5,626 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 5,626 shares Price per share: $0.0000 per share Total shares after grant: 5,626 shares +2 more

5 metrics

Shares granted 5,626 shares Common Stock grant reported on Form 4

Price per share $0.0000 per share Reported grant price for compensation award

Total shares after grant 5,626 shares Direct holdings following transaction

Vesting schedule 100% after one year Shares vest one year from grant award date

Transaction code A Grant, award, or other acquisition of Common Stock

Key Terms

Form 4, Common Stock, Grant, award, or other acquisition, vest, +1 more

5 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

""transaction_code_description": "Grant, award, or other acquisition""

vest financial

"These shares vest 100% one year from grant award date."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

direct ownership financial

""ownership_type": "direct""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KENNEDY JOHN C

(Last) (First) (Middle)

600 N. CENTENNIAL ST.

(Street)

ZEELAND MICHIGAN 49464

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENTEX CORP [ GNTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		5,626(1)	A	$0.00	5,626	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares vest 100% one year from grant award date.

Remarks:

	/s/ Scott Ryan for John Kennedy by Power of Attorney	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GENTEX (GNTX) director John C. Kennedy report?

John C. Kennedy reported receiving a grant of 5,626 shares of GENTEX Common Stock. This is a compensation-related equity award, not an open-market purchase or sale, and reflects additional direct ownership through stock-based compensation.

Was John C. Kennedy’s GENTEX Form 4 transaction a stock purchase or sale?

The Form 4 shows an acquisition through a grant or award, not a market trade. Kennedy did not buy the shares in the open market or sell existing shares; he received them as a compensation-related stock award.

How many GENTEX (GNTX) shares did John C. Kennedy receive in this award?

He received 5,626 shares of GENTEX Common Stock in this grant. The transaction price per share is reported as zero because it is a stock-based compensation award, not a cash purchase on the open market.

When do John C. Kennedy’s newly granted GENTEX shares vest?

According to the footnote, the 5,626 granted shares vest 100% one year from the grant award date. Until vesting, the award is subject to service or other conditions described in the underlying equity plan.

What is John C. Kennedy’s GENTEX shareholding after this Form 4 transaction?

After the award, Kennedy is reported as directly holding 5,626 shares of GENTEX Common Stock. This figure reflects his direct ownership following the grant of the compensation-related stock award disclosed in the Form 4.

Does the GENTEX Form 4 for John C. Kennedy involve any stock options or derivatives?

The filing data show only a non-derivative transaction in Common Stock. There are no option exercises or other derivative transactions reported, and the derivative summary section for this Form 4 is empty.